6-002.q:
Administration of medication: Administration of medication, list 2: Liposomal amphotericin B, parenteral
- 6-002.q0 100 mg up to 175 mg
- 6-002.q1 175 mg up to 250 mg
- 6-002.q2 250 mg up to 350 mg
- 6-002.q3 350 mg up to 450 mg
- 6-002.q4 450 mg up to 550 mg
- 6-002.q5 550 mg up to 650 mg
- 6-002.q6 650 mg up to 750 mg
- 6-002.q7 750 mg up to 850 mg
- 6-002.q8 850 mg up to 950 mg
- 6-002.q9 950 mg up to 1,150 mg
- 6-002.qa 1,150 mg up to 1,350 mg
- 6-002.qb 1,350 mg up to 1,550 mg
- 6-002.qc 1,550 mg up to 1,750 mg
- 6-002.qd 1,750 mg up to 1,950 mg
- 6-002.qe 1,950 mg up to 2,150 mg
- 6-002.qf 2,150 mg up to 3,150 mg
- 6-002.qg 3,150 mg up to 4,150 mg
- 6-002.qh 4,150 mg up to 5,150 mg
- 6-002.qj 5,150 mg up to 6,150 mg
- 6-002.qk 6,150 mg up to 8,650 mg
- 6-002.qm 8,650 mg up to 11,150 mg
- 6-002.qn 11,150 mg up to 13,650 mg
- 6-002.qp 13,650 mg up to 18,650 mg
- 6-002.qq 18,650 mg up to 23,650 mg
- 6-002.qr 23,650 mg up to 28,650 mg
- 6-002.qs 28,650 mg up to 33,650 mg
- 6-002.qt 33,650 mg up to 38,650 mg
- 6-002.qu 38,650 mg up to 43,650 mg
- 6-002.qv 43,650 mg or more
Source
Provided by the non-profit organization “Was hab’ ich?” gemeinnützige GmbH on behalf of the Federal Ministry of Health (BMG).